Seeking Alpha
28 Jun 2026, 13:15 UTC · 20w ago
Crescent Capital: A Tactical 13% Yielding Case To Buy
Impact · against what's priced in
Crescent Capital (CCAP) presents a tactical value opportunity due to a steep discount to NAV and a high, covered yield. While the stock is underperforming its index, the fundamentals support a potential price correction.
- CCAP+0.40
No priced-in read yet
- In context
The stock's 40% discount to NAV and 13% dividend yield supported by strong earnings coverage suggest a significant valuation gap.
Read from the article alone
- Actual

Top 1 mover · tap to explore




